Biomason is pioneering a sustainable approach to concrete production by utilizing biotechnology to create biocement, which serves as a natural alternative to traditional Portland cement. The company harnesses the power of microorganisms to facilitate the formation of calcium carbonate crystals, effectively binding carbon and eliminating the high-energy processes typically associated with cement manufacturing. This innovative method not only reduces carbon emissions but also sequesters carbon within the concrete itself, making it a more environmentally friendly option. By integrating natural materials and biological processes, Biomason is transforming the concrete industry and addressing one of the significant contributors to global carbon emissions.

The production of Biomason's biocement takes place at the Biobeton factory in Denmark, developed in collaboration with IBF, the largest precast concrete producer in the region. This facility employs standard industrial equipment, such as mixers and presses, but has been adapted to accommodate the unique requirements of biocementation. By utilizing existing infrastructure while implementing innovative biotechnological processes, Biomason is positioned to offer a viable and sustainable alternative to conventional concrete production, thereby supporting the construction industry in reducing its environmental impact.

United States

Biomason is a unique biotechnology start-up manufacturing company with a natural process that will revolutionize the building and construction industry. Biomason employs natural microorganisms and chemical processes to manufacture biological cement-based masonry building materials.Biomasonmakes biocement by usingBacillus to hydrolyze urea. This process producesCO2, whichcombines with calcium ions to form calcium carbonate. This process binds particles of sand and rock together to make tiles.

Biomason

Company Details